Daily News Digest: Reuters Health News Headlines - Yahoo! News

Yahoo! Alerts

Yahoo! News | My Alerts | Edit Alert

Sunday, June 26, 2011 12:03 AM PDT

Today's Reuters Health News Headlines - Yahoo! News: Bristol diabetes pill tied to certain cancers France bans UK garden firm's seeds in E.coli scare Global diabetes epidemic balloons to 350 million Novo Nordisk says degludec insulin outperforms Sanofi rival Amylin study shows insignificant heart rhythm link FDA rejects Pain, Pfizer anti-abuse painkiller Abbott says blood sugar monitoring devices stolen Endo recalls two lots of pain drug Sanofi diabetes drug shown to work as well as Byetta Analysis: Scientists getting closer to artificial pancreas Heart risks lower in men who get enough vitamin D FDA urges caution on Amgen, J&J anemia drugs Dutch may label some cannabis as a hard drug Prenatal folic acid doesn't boost sons' fertility Kidney improvement sustained by Abbott drug: study Bristol diabetes pill tied to certain cancers Sat,25 Jun 2011 02:34 PM PDT Reuters - SAN DIEGO (Reuters) - A new type of diabetes pill being developed by Bristol-Myers Squibb and AstraZeneca was effective in a two-year study but more bladder and breast cancers have been found in patients treated with the drug. Full Story1 Top France bans UK garden firm's seeds in E.coli scare Sat,25 Jun 2011 09:01 AM PDT Reuters - PARIS (Reuters) - At least two people suffering from E.coli in the French city of Bordeaux have the strain that caused scores of deaths in Germany, French authorities said, and they halted sales of vegetable seeds from a British gardening firm. Full Story1 Top Global diabetes epidemic balloons to 350 million Sat,25 Jun 2011 08:34 AM PDT Reuters - LONDON/SAN DIEGO (Reuters) - The number of adults with diabetes worldwide has more than doubled since 1980 to 347 million, a far larger number than previously thought and one that suggests costs of treating the disease will also balloon. Full Story1 Top Novo Nordisk says degludec insulin outperforms Sanofi rival Fri,24 Jun 2011 05:00 PM PDT Reuters - COPENHAGEN (Reuters) - Studies showed Novo Nordisk's insulin degludec lowered blood sugar levels with significantly reduced rates of hypoglycaemia when compared with rival Sanofi's Lantus, the Danish firm said on Saturday. Full Story1 Top Amylin study shows insignificant heart rhythm link Fri,24 Jun 2011 04:29 PM PDT Reuters - SAN DIEGO (Reuters) - Analysis of an earlier trial found a "clinically insignificant" link between changes in heart rhythms and use of Bydureon, a long-acting diabetes drug being developed by Amylin Pharmaceuticals, Eli Lilly and Alkermes. Full Story1 Top FDA rejects Pain, Pfizer anti-abuse painkiller Fri,24 Jun 2011 03:46 PM PDT Reuters - BANGALORE (Reuters) - Pfizer Inc and Pain Therapeutics Inc said U.S. health regulators declined to approve their abuse-resistant painkiller Remoxy, less than a week after a similar Pfizer drug was cleared for sale, sending Pain's stock crashing Friday. Full Story1 Top Abbott says blood sugar monitoring devices stolen Fri,24 Jun 2011 02:45 PM PDT Reuters - (Reuters) - Abbott Laboratories said it was working with authorities to retrieve one tractor-trailer shipment of blood glucose monitoring products that was reported stolen on June 19. Full Story1 Top Endo recalls two lots of pain drug Fri,24 Jun 2011 02:40 PM PDT Reuters - (Reuters) - Endo Pharmaceuticals Holdings Inc said it recalled two lots of its pain drug Endocet as it may contain incorrect tablets that have a higher dose of widely used analgesic, acetaminophen. Full Story1 Top Sanofi diabetes drug shown to work as well as Byetta Fri,24 Jun 2011 02:30 PM PDT Reuters - SAN DIEGO (Reuters) - A trial of Sanofi's experimental once-daily drug for Type 2 diabetes, Lyxumia, found that it worked as well as Byetta, a similar drug sold by Amylin and Eli Lilly and Co that is injected twice a day. Full Story1 Top Analysis: Scientists getting closer to artificial pancreas Fri,24 Jun 2011 02:05 PM PDT Reuters - CHICAGO (Reuters) - Researchers are coming closer to developing an "artificial pancreas," a long-sought system of insulin pumps and glucose sensors that deliver insulin to diabetics, mimicking the function of a real pancreas. Full Story1 Top Heart risks lower in men who get enough vitamin D Fri,24 Jun 2011 12:19 PM PDT Reuters - NEW YORK (Reuters Health) - Men who consume the recommended amount of vitamin D are somewhat less likely to suffer a heart attack or stroke than those who get little of the vitamin in their diets, a large U.S. study suggests. Full Story1 Top FDA urges caution on Amgen, J&J anemia drugs Fri,24 Jun 2011 10:37 AM PDT Reuters - NEW YORK (Reuters) - Health regulators urged on Friday more conservative dosing for widely used anemia drugs from Amgen Inc and Johnson & Johnson because of the risk of heart problems. Full Story1 Top Dutch may label some cannabis as a hard drug Fri,24 Jun 2011 10:27 AM PDT Reuters - AMSTERDAM (Reuters) - The Netherlands, famous for its liberal soft drugs policies, said on Friday it may label some highly concentrated forms of cannabis as a hard drug on a par with cocaine or heroin, because of the risk of addiction. Full Story1 Top Prenatal folic acid doesn't boost sons' fertility Fri,24 Jun 2011 10:26 AM PDT Reuters - NEW YORK (Reuters Health) - Young men whose mothers took folic acid supplements while pregnant did not grow up to produce healthier sperm, a small Danish study has found. Full Story1 Top Kidney improvement sustained by Abbott drug: study Fri,24 Jun 2011 10:24 AM PDT Reuters - NEW YORK (Reuters) - Diabetics with moderate to severe chronic kidney disease showed significant and sustained improvement in kidney function through 52 weeks of treatment with a novel drug being developed by Abbott Laboratories, according to data from a midstage clinical trial. Full Story1 Top

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.